ProMed Pharma announces acquisition of SpineThera
SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (1a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma LLC, a leading contract manufacturer of polymer-based drug releasing dosage forms and combination device components, announced yesterday that ProMed Pharma has acquired […]
